Table 3 Data about the breast cancer, its treatment, and recurrence
From: Hepatocellular carcinoma associated other primaries: common types and prognosis
Variable | Value |
|---|---|
Timing of appearance of breast cancer | |
Synchronous with HCC | 2 (40%) |
Metachronous with HCC | 3 (60%) |
➣Breast cancer first | 2 |
➣HCC first | 1 |
Breast pathology | |
IDC | 4 (80%) |
DCIS | 1 (20%) |
Breast tumor focality | |
Unifocal | 4 (80%) |
Multifocal | 1 (20%) |
Breast neoadjuvant therapy | |
No | 4 (80%) |
Yes | 1 (20%) |
Breast surgery | |
None | 1 (20%) |
Modified radical mastectomy | 3 (60%) |
Simple mastectomy | 1 (20%) |
Estrogen receptor status | |
Negative | 0 |
Positive | 4 (80%) |
Progesterone receptor status | |
Negative | 1 (20%) |
Positive | 3 (60%) |
HER2neu status | |
Negative | 2 (40%) |
Positive | 1 (20%) |
Molecular type | |
Luminal B | 4 (80%) |
Pathologic stage | |
Is | 1 (20%) |
II | 3 (60%) |
III | 1 (20%) |
Chest wall recurrence post mastectomy | 0 |